Barbara Hernando
@bhernando.bsky.social
Postdoctoral Junior Leader at CNIO funded by LaCaixa | Cancer genomics, evolution & early detection | Heptathlete forever
It was an honor to take part in the @yalepathology.bsky.social research retreat today! Great science, inspiring discussions, a fun “guess who?”, and wonderful people. Huge thanks to organizers for such a great work! Can’t believe only 2 months left to enjoy this amazing #AitkenLab team ✨
Today was our first Yale Pathology Department retreat - with Klaske, Barbara, Jacob, and Vanessa (we missed you Tanuja!) Great to present our work with a poster and two talks, share ideas, and meet new people
🇨🇦🇪🇸🇬🇧🇳🇱🇺🇸🌎
@yalepathology.bsky.social @bhernando.bsky.social
🇨🇦🇪🇸🇬🇧🇳🇱🇺🇸🌎
@yalepathology.bsky.social @bhernando.bsky.social
October 30, 2025 at 9:38 PM
It was an honor to take part in the @yalepathology.bsky.social research retreat today! Great science, inspiring discussions, a fun “guess who?”, and wonderful people. Huge thanks to organizers for such a great work! Can’t believe only 2 months left to enjoy this amazing #AitkenLab team ✨
Reposted by Barbara Hernando
A trio of talks this week: Grand Rounds @jhu.edu yesterday. Then @bhernando.bsky.social (who has only been here a fortnight!) and I gave talks at the NYC Genome Integrity Discussion group @rockefeller.edu. Thanks for inviting us Agata Smogorzewska and Philipp Oberdoerffer
@yalepathology.bsky.social
@yalepathology.bsky.social
October 10, 2025 at 8:46 PM
A trio of talks this week: Grand Rounds @jhu.edu yesterday. Then @bhernando.bsky.social (who has only been here a fortnight!) and I gave talks at the NYC Genome Integrity Discussion group @rockefeller.edu. Thanks for inviting us Agata Smogorzewska and Philipp Oberdoerffer
@yalepathology.bsky.social
@yalepathology.bsky.social
Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩
Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
🥳 Today we welcome Dr Bárbara Hernando @bhernando.bsky.social to the #AitkenLab @yaleschoolofmed.bsky.social
Bárbara joins us from #CNIO as part of her @caixaresearch.bsky.social Postdoctoral Junior Leader Fellowship
@yalepathology.bsky.social @yalecancer.bsky.social @cniostopcancer.bsky.social
Bárbara joins us from #CNIO as part of her @caixaresearch.bsky.social Postdoctoral Junior Leader Fellowship
@yalepathology.bsky.social @yalecancer.bsky.social @cniostopcancer.bsky.social
September 29, 2025 at 4:31 PM
Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩
Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
Reposted by Barbara Hernando
#CNIOStopCancer develop test that predicts which patients will not respond to cancer chemotherapy. They have identified biomarkers which, in clinical practice, would allow for more effective treatments and the avoidance of side effects.
http://bit.ly/465QqnR
http://bit.ly/465QqnR
June 23, 2025 at 4:14 PM
#CNIOStopCancer develop test that predicts which patients will not respond to cancer chemotherapy. They have identified biomarkers which, in clinical practice, would allow for more effective treatments and the avoidance of side effects.
http://bit.ly/465QqnR
http://bit.ly/465QqnR
Reposted by Barbara Hernando
Un estudio del #CNIOStopCancer descubre biomarcadores que predicen qué pacientes no responderán a la quimioterapia contra el cáncer. Podrían servir para descartar tratamientos que no van a funcionar, pero provocan efectos secundarios y son caros.
http://bit.ly/4lj1QJn
http://bit.ly/4lj1QJn
June 23, 2025 at 3:21 PM
Un estudio del #CNIOStopCancer descubre biomarcadores que predicen qué pacientes no responderán a la quimioterapia contra el cáncer. Podrían servir para descartar tratamientos que no van a funcionar, pero provocan efectos secundarios y son caros.
http://bit.ly/4lj1QJn
http://bit.ly/4lj1QJn
Reposted by Barbara Hernando
🚨Chemo treatment upgrade!🚨
Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
www.nature.com
June 23, 2025 at 9:03 AM
🚨Chemo treatment upgrade!🚨
Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇
💥New preprint from the @gmaci.bsky.social lab!
Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!
Check out our threat to learn more about our work👇
Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!
Check out our threat to learn more about our work👇
If tumour genome evolution is deterministic, can we forecast genomic changes? Yes we can! At least for oncogene amps and tumour suppressor dels. @bhernando.bsky.social Angel Fernandez-Sanroman present our method for forecasting driver gene copy number change. Preprint: bit.ly/4kxF14y ⬇️1/
Forecasting oncogene amplification and tumour suppressor deletion
Oncogene amplification and tumour suppressor deletion can drive tumour initiation, progression and treatment resistance. Detection at diagnosis often signals poor prognosis, but it can also enable opp...
bit.ly
June 10, 2025 at 2:23 PM
💥New preprint from the @gmaci.bsky.social lab!
Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!
Check out our threat to learn more about our work👇
Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!
Check out our threat to learn more about our work👇
Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩
May 14, 2025 at 5:15 PM
Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩
Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, Maria Escobar will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community meetings.embo.org/event/25-ane...
Chromosome Segregation and Aneuploidy
Aneuploidy is a hallmark of cancer and developmental disorders such as Down syndrome. Understanding how cells accomplish faithful chromosome segregation and how chromosomal instability (CIN) impacts …
meetings.embo.org
April 27, 2025 at 5:36 PM
Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, Maria Escobar will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community meetings.embo.org/event/25-ane...
Ready for #AACR25! Excited for five full days of talks, posters and educational sessions in cancer research, and also for catching up with colleagues and friends 🤩
April 26, 2025 at 10:17 PM
Ready for #AACR25! Excited for five full days of talks, posters and educational sessions in cancer research, and also for catching up with colleagues and friends 🤩